EyePod
- Épisodes
- 131
- Parution
- toutes les deux semaines
- Dernier épisode
- 13 Nov 2026
À propos du podcast
Hosted by the award-winning editorial staff of Ophthalmology Times®, EyePod podcasts feature the latest updates and resources most relevant to professionals across the eyecare industry.
Épisodes 131
S1 Ep5: OT Roundup Ep. 5: FDA NAION warning for GLP-1 drugs, LEMS vs ocular MG, Eyedaptic Eva, AFib
On this episode of OT Roundup, Ophthalmology Times covers the FDA's new NAION warning for GLP-1 receptor agonists, with an Expert Insight from Veeral Sheth, MD, University Retina. Also in this episode: how to …
Notes de l’épisode
On this episode of OT Roundup, Ophthalmology Times covers the FDA's new NAION warning for GLP-1 receptor agonists, with an Expert Insight from Veeral Sheth, MD, University Retina. Also in this episode: how to tell Lambert-Eaton myasthenic syndrome from ocular myasthenia gravis, a new AI assistant from Eyedaptic for patients with retinal disease, and a study linking retinal imaging to atrial fibrillation. Links below!
1. FDA requires NAION warning across the GLP-1 receptor agonist class
2. Distinguishing Lambert-Eaton myasthenic syndrome from ocular myasthenia gravis in the eye clinic
3. Eyedaptic launches Eva, an agentic AI visual assistant for patients with retinal disease
4. Retinal imaging as a window into atrial fibrillationS1 Ep4: OT Roundup Ep. 4: 3 FDA approvals, Duravyu LUCIA miss, brepocitinib, GLP-1 and DME
This edition of OT Roundup covers 3 FDA approvals announced on a single day, a second phase 3 miss for Duravyu in wet age-related macular degeneration (AMD) with Veeral Sheth, MD, positive phase 3 results for …
Notes de l’épisode
This edition of OT Roundup covers 3 FDA approvals announced on a single day, a second phase 3 miss for Duravyu in wet age-related macular degeneration (AMD) with Veeral Sheth, MD, positive phase 3 results for brepocitinib in noninfectious uveitis, and registry data on GLP-1 receptor agonists and anti-VEGF treatment in diabetic macular edema (DME).3: OT Roundup Ep. 3: Optogenetics Nobel Prize, remigromig in DME, Stargardt, eye transplant
This edition of OT Roundup covers the Nobel Prize in Physiology or Medicine for optogenetics and its link to MCO-010 in retinitis pigmentosa, BRUNELLO phase 2b/3 results for remigromig in diabetic macular edema …
Notes de l’épisode
This edition of OT Roundup covers the Nobel Prize in Physiology or Medicine for optogenetics and its link to MCO-010 in retinitis pigmentosa, BRUNELLO phase 2b/3 results for remigromig in diabetic macular edema (DME) with Veeral Sheth, MD, phase 3 DRAGON results for tinlarebant in Stargardt disease, and what the first total human eye transplant has taught surgeons.3: Beyond the Walls: Dry eye, downward dog, and doing medicine differently with Priya M. Mathews, MD, MPH
In this episode of the Ophthalmology Times® "Beyond the Walls" podcast, host Deborah Ristvedt, DO, sits down with Priya Mathews, MD, a cornea, cataract, and refractive surgeon, dry eye expert, and educator, to …
Notes de l’épisode
In this episode of the Ophthalmology Times® "Beyond the Walls" podcast, host Deborah Ristvedt, DO, sits down with Priya Mathews, MD, a cornea, cataract, and refractive surgeon, dry eye expert, and educator, to explore the experiences and passions that have shaped her career and her approach to patient care.
Mathews shares how a mentor sparked a lifelong commitment to dry eye care — a patient population she felt was historically underserved. She discusses building a dedicated dry eye rehab clinic, why treating the ocular surface is essential for premium cataract outcomes, and how her 15-year yoga practice has woven itself into her vision for whole-patient care. From navigating early career self-doubt to designing a practice built around purpose, Mathews offers an honest and inspiring look at what it means to follow your calling in medicine.
Check out more episodes of Beyond the Walls at https://www.ophthalmologytimes.com/podcasts/beyond-the-walls
#Ophthalmology #EyeCare #BeyondTheWalls #DryEye #OcularSurface #WomenInOphthalmology #Podcast #OphthalmologyTimes2: OT Roundup: MOGENRY data, RCA report, SYD-101, OCU410
Episode 2 of OT Roundup is here. Lucia Gambuzza and co-host Veeral Sheth, MD, break down 4-year durability data for MOGENRY in retinitis pigmentosa, RCA's first State of Retina Care report, the FDA's upcoming …
Notes de l’épisode
Episode 2 of OT Roundup is here. Lucia Gambuzza and co-host Veeral Sheth, MD, break down 4-year durability data for MOGENRY in retinitis pigmentosa, RCA's first State of Retina Care report, the FDA's upcoming review of SYD-101 for pediatric myopia, and new Phase 2 data on OCU410 for geographic atrophy.
MOGENRY 4-year data: https://www.ophthalmologytimes.com/view/retina-society-2026-mco-010-optogenetic-therapy-maintains-visual-acuity-gains-through-4-years-in-advanced-rp
RCA's State of Retina Care report: https://www.ophthalmologytimes.com/view/rca-releases-first-state-of-retina-care-report
FDA Advisory Committee on SYD-101: https://www.ophthalmologytimes.com/view/fda-advisory-committee-syd-101-pediatric-myopia-october-30
Nimesh Patel, MD on pediatric progressive myopia: https://www.ophthalmologytimes.com/view/pediatric-progressive-myopia-epidemic-permanent-vision-lossOCU410 Phase 2 data: https://www.ophthalmologytimes.com/view/retina-society-2026-medium-dose-ocu410-gene-therapy-cuts-geographic-atrophy-progression-up-to-32-in-phase-2-trial
2: Eichenbaum Acorns: A passion for retina science with Andrea Gibson, PhD, and Erin C. Henry, PhD
Eichenbaum Acorns is an editorially independent series powered by Modern Retina and hosted by David A. Eichenbaum, MD, FASRS, partner and director of research at Retina Vitreous Associates of Florida. This …
Notes de l’épisode
Eichenbaum Acorns is an editorially independent series powered by Modern Retina and hosted by David A. Eichenbaum, MD, FASRS, partner and director of research at Retina Vitreous Associates of Florida. This podcast series explores the overlooked corners of the retina profession through candid conversations with thought leaders. Eichenbaum is the Yiddish word for oak tree, and the aim of this series is to plant acorns of insight that grow into oaks of understanding.
In this episode, Eichenbaum speaks with two longtime friends and retina drug-development veterans: Andrea Gibson, PhD, executive vice president of medical collaborations at Ocular Therapeutix, and Erin C. Henry, PhD, AVP of Ophthalmology, General and Specialty Medicine, Value and Implementation, Global Medical and Scientific Affairs at Merck Research Labs.
Grab a seat for this one — it's part reunion, part masterclass. Gibson and Henry were there at the dawn of anti-VEGF therapy, trading stories from the front lines of a field that changed medicine forever, and 20 years later, they're still just as obsessed with the science. They swap laughs about "stumbling into" careers nobody could have mapped out for them, get real about the mentors who doubted the move to industry, and issue a challenge to the field: stop letting the next generation stumble in the same way they did. Equal parts nostalgia, candor, and a rallying cry for what comes next.
Check out more episodes of Eichenbaum Acorns, powered by Modern Retina, at https://www.ophthalmologytimes.com/podcasts/eichenbaum-acorns
1: OT Roundup ep. 1: ADHD's eye link, MOGENRY's BLA, and myopia news
The debut episode of OT Roundup, a new biweekly news podcast from Ophthalmology Times. This episode covers new research on ADHD's ocular signature, a surgeon's personal experience with a trifocal IOL, the FDA's …
Notes de l’épisode
The debut episode of OT Roundup, a new biweekly news podcast from Ophthalmology Times. This episode covers new research on ADHD's ocular signature, a surgeon's personal experience with a trifocal IOL, the FDA's acceptance of a gene-agnostic therapy for retinitis pigmentosa, and the AMA's move to classify myopia as a disease—plus Expert Insight from Dr. Veeral Sheth.Beyond the Walls: Risks, reinvention, and redefining the patient experience with Alison D. Early, MD
In this latest episode of the Ophthalmology Times® “Beyond the Walls” podcast, host Deborah Ristvedt, DO, sits down with Alison D. Early, MD, a cataract and refractive surgeon, innovator, and entrepreneur at …
Notes de l’épisode
In this latest episode of the Ophthalmology Times® “Beyond the Walls” podcast, host Deborah Ristvedt, DO, sits down with Alison D. Early, MD, a cataract and refractive surgeon, innovator, and entrepreneur at Signature Cataract and Laser Consultants in Cincinnati, Ohio, to explore the personal turning point that led Early to step away from the security of a large multispecialty practice and build a practice of her own.
The conversation covers the galvanizing patient encounter that changed Early’s trajectory, her philosophy of human-centered care, and her advice to surgeons navigating the early stages of their careers.
Check out more episodes of Beyond The Walls at
https://www.ophthalmologytimes.com/podcasts/beyond-the-walls
#Ophthalmology #EyeCare #BeyondTheWalls #PrivatePractice #WomenInOphthalmology #PatientExperience #Entrepreneurship #OphthalmologyTimesEichenbaum Acorns: Piloting a career pivot with David J. Tanzer, MD, ABO
Eichenbaum Acorns is an editorially independent series powered by Modern Retina and hosted by David A. Eichenbaum, MD, FASRS, partner and director of research at Retina Vitreous Associates of Florida. This …
Notes de l’épisode
Eichenbaum Acorns is an editorially independent series powered by Modern Retina and hosted by David A. Eichenbaum, MD, FASRS, partner and director of research at Retina Vitreous Associates of Florida. This podcast series explores the overlooked corners of the retina profession through candid conversations with thought leaders.
In this episode, Eichenbaum speaks with David J. Tanzer, MD, ABO, chief medical officer (CMO) at Lexitas Pharma Services, Inc., about a career that travels from the cockpit through clinical practice to the boardroom. A former US Navy flight surgeon turned three-time CMO, Tanzer shares how a chance rotation in San Diego led him into ophthalmology, why he still misses hands-on patient care, and what advice he'd give physicians considering a path beyond pure clinical medicine.
Check out more episodes of Eichenbaum Acorns, powered by Modern Retina, at https://www.ophthalmologytimes.com/podcasts/eichenbaum-acorns
Beyond the Walls: Curiosity, courage, and chasing a life of giving with John P. Berdahl, MD
In this episode of the Ophthalmology Times® "Beyond The Walls" podcast, host Deborah Ristvedt, DO, sits down with colleague John P. Berdahl, MD, of Vance Thompson Vision, to explore the personal story behind a …
Notes de l’épisode
In this episode of the Ophthalmology Times® "Beyond The Walls" podcast, host Deborah Ristvedt, DO, sits down with colleague John P. Berdahl, MD, of Vance Thompson Vision, to explore the personal story behind a career defined by curiosity, persistence, and a commitment to giving back.
Berdahl shares formative childhood experiences, early struggles in medical school, and the defining moments that shaped his path in ophthalmology. He discusses the innovations that have marked his career, including OPAP, a negative pressure goggle system for glaucoma, and a free toric IOL rotation calculator used by thousands of surgeons each month. He also speaks candidly about a high-profile business failure, the resilience it took to recover, and what he has learned about leadership along the way.
The conversation closes with reflections on mentorship, family, and legacy — and what it truly means to give more than you take.
Check out more episodes of Beyond The Walls at
https://www.ophthalmologytimes.com/podcasts/beyond-the-walls
#Ophthalmology #EyeCare #BeyondTheWalls #Innovation #Entrepreneurship #Mentorship #Podcast #OphthalmologyTimesEichenbaum Acorns: A full-circle moment in retina for Caroline R. Baumal, MD
Eichenbaum Acorns is an editorially independent series powered by Modern Retina and hosted by David A. Eichenbaum, MD, FASRS, partner and director of research at Retina Vitreous Associates of Florida. This …
Notes de l’épisode
Eichenbaum Acorns is an editorially independent series powered by Modern Retina and hosted by David A. Eichenbaum, MD, FASRS, partner and director of research at Retina Vitreous Associates of Florida. This podcast series explores the overlooked corners of the retina profession through candid conversations with thought leaders. Eichenbaum is the Yiddish word for oak tree, and the aim of this series is to plant acorns of insight that grow into oaks of understanding.
In this episode, Eichenbaum speaks with Caroline R. Baumal, MD, recently chief medical officer (CMO) of Apellis Pharmaceuticals, about a career that has moved between clinical practice, academic medicine, imaging research, and industry leadership—and what she has learned along the way.
Check out other episodes of Eichenbaum Acorns, powered by Modern Retina.
Embracing the Interventional Glaucoma Mindset: A Paradigm Shift in Contemporary Glaucoma Management
In this podcast, experts Mary Qiu, MD; Paul Singh, MD; and Danica J. Marrelli, OD, FAAO; discuss interventional glaucoma. This more proactive management approach aims to minimize the challenges of topical …
Notes de l’épisode
In this podcast, experts Mary Qiu, MD; Paul Singh, MD; and Danica J. Marrelli, OD, FAAO; discuss interventional glaucoma. This more proactive management approach aims to minimize the challenges of topical glaucoma management with the earlier use of procedures.Eichenbaum Acorns: From clinic to C-suite with Jay S. Duker, MD, and Ramiro Ribeiro, MD, PhD
Eichenbaum Acorns is an editorially independent series powered by Modern Retina and hosted by David A. Eichenbaum, MD, FASRS, partner and director of research at Retina Vitreous Associates of Florida. This …
Notes de l’épisode
Eichenbaum Acorns is an editorially independent series powered by Modern Retina and hosted by David A. Eichenbaum, MD, FASRS, partner and director of research at Retina Vitreous Associates of Florida. This podcast series explores the overlooked corners of the retina profession through candid conversations with thought leaders. Eichenbaum is the Yiddish word for oak tree, and the aim of this series is to plant acorns of insight that grow into oaks of understanding.
In this episode, Eichenbaum speaks with Jay S. Duker, MD, president and CEO of EyePoint Pharmaceuticals and a board director, and Ramiro Ribeiro, MD, PhD, chief medical officer of EyePoint Pharmaceuticals, about the professional decisions that led each of them from clinical and academic training into pharmaceutical leadership—and what they have learned along the way.
Searching for Silence: Corneal Sensitivity Testing in NK
In this podcast, experts Francis Mah, MD; and Amy Nau, OD, FAAO, Dipl, CCLRT; discuss how to identify neurotrophic keratitis in practice, highlighting indications for corneal sensitivity testing based on …
Notes de l’épisode
In this podcast, experts Francis Mah, MD; and Amy Nau, OD, FAAO, Dipl, CCLRT; discuss how to identify neurotrophic keratitis in practice, highlighting indications for corneal sensitivity testing based on patient history and examination findings. Faculty will also examine how to stage and treat neurotrophic keratitis once diagnosed.Beyond the Walls: Leading with love, loyalty, and a team first philosophy with Vance Thompson, MD
In this latest episode of the Ophthalmology Times® “Beyond The Walls” podcast, host Deborah Ristvedt, DO, sits down with her ophthalmology practice partner and mentor Vance Thompson, MD, to explore the origins …
Notes de l’épisode
In this latest episode of the Ophthalmology Times® “Beyond The Walls” podcast, host Deborah Ristvedt, DO, sits down with her ophthalmology practice partner and mentor Vance Thompson, MD, to explore the origins and ongoing impact of a team first culture at Vance Thompson Vision. The conversation covers Thompson's early frustrations with practice dynamics, his turn toward business education, and the philosophy that has guided his career and practice growth.
Thompson traces his thinking back to the late 1990s, when despite working with what he describes as "nice people," his practice was seeing more team and patient complaints than he expected. Encouraged by his brother-in-law, a physician-turned-hospital administrator, Thompson began studying the business side of medicine. He attended a course in Boca Raton, Florida, and worked with Jim Gilmore, coauthor of The Experience Economy, whose framework—"work is theater and every business a stage"—helped him reframe how he thought about patient care delivery.
The pivotal insight came when Thompson recognized that teachings focused on the customer, while he was focused on the patient. "The team experience is something that I have to have perfect, we have to have perfect before we're gonna have a great patient experience," he explains. This realization led to what became his signature and deliberately provocative principle: The patient comes second.
Thompson acknowledges the reaction that framing typically draws. "I've heard audible gasps from groups of surgeons," he says, adding that the point is not to deprioritize patients but to challenge a culture in medicine where staff are treated "less than." His argument is that an authentically cared-for team creates an environment patients feel immediately. "I don't know exactly what's going on here, but I love how they treat each other and I love how they treat me," he describes patients saying.
He also connects team first culture to burnout prevention, recounting a colleague who told him he feared he was burning out. Thompson's response: "Are you operating on eyes or are you operating on people?" Reconnecting with the human dimension of the work, he suggests, is central to sustaining energy across a career. "I always want to remember I'm a doctor first, I'm an ophthalmologist second, I'm a refractive surgeon third."
Thompson credits legendary UCLA basketball coach John Wooden with giving him "the guts to use the L word in the workplace," drawing a distinction between the love shared with family and a professional love rooted in genuine care for colleagues. He describes this openly with prospective partners: "I want them to know about the mush of me from the beginning," noting that those not open to that kind of relationship will eventually leave. He concludes that he views shared values around caring for fellow humans as a foundation for both culture and growth at Vance Thompson Vision.
Eichenbaum Acorns: Paying it forward with Christina Y. Weng, MD, MBA, FASRS
Eichenbaum Acorns is an editorially independent series powered by Modern Retina and hosted by David A. Eichenbaum, MD, FASRS, partner and director of research at Retina Vitreous Associates of Florida. This …
Notes de l’épisode
Eichenbaum Acorns is an editorially independent series powered by Modern Retina and hosted by David A. Eichenbaum, MD, FASRS, partner and director of research at Retina Vitreous Associates of Florida. This podcast series explores the overlooked corners of the retina profession through candid conversations with thought leaders. Eichenbaum is the Yiddish translation for acorn tree, and the aim of this series is to plant acorns of insight that grow into oaks of understanding.
In this episode of Eichenbaum Acorns, Eichenbaum speaks with Christina Y. Weng, MD, MBA, FASRS, about her career path, mentorship, education, and evolving clinical research in retina. Weng, who is professor and the Alice R. McPherson Retina Research Foundation Chair in Ophthalmology, and fellowship program director, vitreoretinal diseases and surgery with Baylor College of Medicine in Houston, Texas, reflects on joining Baylor straight out of fellowship at Bascom Palmer Eye Institute in Miami, Florida, and building her career there over more than a decade.
Fun fact! Christina Y. Weng, MD, MBA, FASRS, is also host of The Retina TL;DR, powered by Modern Retina. Check out these episodes!
Eichenbaum Acorns: Collaborative retina care with Jeffry D. Gerson, OD, FAAO
Eichenbaum Acorns is an editorially independent series powered by Modern Retina and hosted by David A. Eichenbaum, MD, FASRS, partner and director of research at Retina Vitreous Associates of Florida. This …
Notes de l’épisode
Eichenbaum Acorns is an editorially independent series powered by Modern Retina and hosted by David A. Eichenbaum, MD, FASRS, partner and director of research at Retina Vitreous Associates of Florida. This podcast series explores the overlooked corners of the retina profession through candid conversations with thought leaders. Eichenbaum is the Yiddish translation for acorn tree, and the aim of this series is to plant acorns of insight that grow into oaks of understanding.
In this special cross-brand episode with Optometry Times, Eichenbaum speaks with Jeffry D. Gerson, OD, FAAO, about career development, mentorship, and collaboration between optometry and ophthalmology in retinal care.
Gerson practices in a collaborative OD-MD setting at Grin Eye Care in Olathe and Leawood, Kansas, where his work includes primary care as well as secondary care with an emphasis on retinal disease.
The Presbyopia-Correcting and Toric IOL Playbook: Game-Changing Surgical Strategies to Enhance Patient Outcomes
In this podcast, eye care expert Uday Devgan, MD, FACS, FRCS, reviews premium intraocular lens (IOL) options, including presbyopia-correcting IOLs and toric IOLs for patients with astigmatism.
Interventional Glaucoma: The Convergence of Surgical Innovation and Therapeutic Hope
In this podcast, Philadelphia cornea and glaucoma surgeon Brian Shafer, MD, discusses the procedures and processes involved in interventional glaucoma, which offers earlier options such as laser, drug-releasing …
Notes de l’épisode
In this podcast, Philadelphia cornea and glaucoma surgeon Brian Shafer, MD, discusses the procedures and processes involved in interventional glaucoma, which offers earlier options such as laser, drug-releasing implants, MIGS, and MIBS, with less reliance on topical medications in appropriate patients.Beyond The Walls: Mentorship, medicine, and making sense of microbiology with William B. Trattler, MD
In this latest episode of the Ophthalmology Times® “Beyond The Walls” podcast, host Deborah Ristvedt, DO, of Vance Thompson Vision, sits down with William B. Trattler, MD, to explore the experiences …
Notes de l’épisode
In this latest episode of the Ophthalmology Times® “Beyond The Walls” podcast, host Deborah Ristvedt, DO, of Vance Thompson Vision, sits down with William B. Trattler, MD, to explore the experiences, influences, and philosophies that have shaped his career in ophthalmology. The discussion covers early inspirations, approaches to teaching, mentorship initiatives, clinical collaboration, and the evolving role of technology in patient care.
Trattler traces his introduction to medicine to his father, an ophthalmologist, whom he describes as “just such an incredible role model.” During medical school, Trattler coauthored Clinical Microbiology Made Ridiculously Simple, motivated by a desire to simplify complex material. “We should just make it ridiculously simple,” he explains, highlighting his use of visual aids and associations to enhance learning. This philosophy carries into his clinical practice, where he emphasizes simplifying the interpretation of diagnostic tools by distinguishing “what’s normal, versus abnormal,” while recognizing the variability in findings and the importance of repetition and experience.
Mentorship is a central theme, reflected in Trattler’s development of the Rising Stars in Ophthalmology program. The conversation also includes reflections on balancing professional and personal life, ongoing practice growth, generational transitions, and the future of ophthalmology.
IOLs: What Every Surgeon Needs to Know | Ep. 1: IOL Biomaterials
IOLs: What Every Surgeon Needs to Know is an editorially independent video and podcast series from Ophthalmology Times, hosted by Douglas D. Koch, MD, Professor and Allen, Mosbacher, and Law Chair in …
Notes de l’épisode
IOLs: What Every Surgeon Needs to Know is an editorially independent video and podcast series from Ophthalmology Times, hosted by Douglas D. Koch, MD, Professor and Allen, Mosbacher, and Law Chair in Ophthalmology at the Cullen Eye Institute, Baylor College of Medicine in Houston, Texas.
In each episode, Koch will be joined by different expert guests to discuss cutting-edge advancements in intraocular lens (IOL) technology and cataract surgery.
In this inaugural episode, Koch is joined by Liliana Werner, MD, PhD, Benning Presidential Endowed Chair and co-director of the Intermountain Ocular Research Center at the Moran A. Eye Center at the University of Utah in Salt Lake City, to explore IOL biomaterials.
🎧 Listen as Douglas D. Koch, MD, and Liliana Werner, MD, PhD, discuss IOL biomaterials and emerging lens technologies.
MacTel Decoded: Rethinking Conventional Approaches with Novel Neuroprotective Strategies
In this podcast, experts Charles C. Wykoff, MD, PhD, FASRS; Jed H. Assam, MD, MS; Diana V. Do, MD; and Dante Pieramici, MD, FASRS; discuss the diagnosis, clinical features, and evolving management strategies …
Notes de l’épisode
In this podcast, experts Charles C. Wykoff, MD, PhD, FASRS; Jed H. Assam, MD, MS; Diana V. Do, MD; and Dante Pieramici, MD, FASRS; discuss the diagnosis, clinical features, and evolving management strategies for patients diagnosed with macular telangiectasia (MacTel) type 2.Eichenbaum Acorns: Mentorship, momentum, and the making of a retina podcast
Eichenbaum Acorns is an editorially independent series powered by Modern Retina and hosted by David A. Eichenbaum, MD, FASRS, partner and director of research at Retina Vitreous Associates of Florida. This …
Notes de l’épisode
Eichenbaum Acorns is an editorially independent series powered by Modern Retina and hosted by David A. Eichenbaum, MD, FASRS, partner and director of research at Retina Vitreous Associates of Florida. This Q&A-style article and podcast series explores the overlooked corners of the retina specialist profession through candid conversations with thought leaders. Eichenbaum is the German translation for acorn tree, and the aim of this series is to plant acorns of insight that grow into oaks of understanding.
In this installment, Eichenbaum talks with Jayanth Sridhar, MD, who saw an opportunity to bring retina education into the daily commute of ophthalmologists. What started as a simple idea during a long drive grew into Sridhar’s Straight From the Cutter’s Mouth: A Retina Podcast. Sridhar explains how the podcast began, the early challenges he faced, and what he learned along the way.
Sridhar is associate professor of clinical ophthalmology at Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, in Miami, Florida, and serves as chief of ophthalmology for the Olive View Medical Center, part of Los Angeles County Department of Health Services, in Los Angeles, California.
When Mites Meet Their Match: Empowering Patients With Targeted Treatment for Demodex Blepharitis
In this podcast, expert Mile Brujic, OD, FAAO, discusses the burden, diagnosis, and management of Demodex blepharitis, highlighting a recently approved targeted treatment option.
Glaucoma 2026: Which emerging technologies will change practice?
Joel Schuman, MD, of Wills Eye Hospital in Philadelphia, sits down with Sheryl Stevenson, executive editor of the Eye Care Network, for a discussion about emerging technologies that may influence glaucoma care …
Notes de l’épisode
Joel Schuman, MD, of Wills Eye Hospital in Philadelphia, sits down with Sheryl Stevenson, executive editor of the Eye Care Network, for a discussion about emerging technologies that may influence glaucoma care as clinicians look toward 2026.
Schuman highlights artificial intelligence for imaging and risk prediction, noting that “the performance really rivals expert readers and the regulatory pathways are clear.” He also reviews remote monitoring, sustained-release drug delivery, and procedural innovations such as direct selective laser trabeculoplasty.
Addressing adoption challenges, Schuman outlines evidence, workflow, economics, and interoperability as key factors, noting that “The winners don’t have to be the flashiest tools in 2026. They’ll be the ones that make a busy clinic run better.”Eichenbaum Acorns: Inside the mindset of an early adopter with Jordan Graff, MD
Eichenbaum Acorns is an editorially independent series powered by Modern Retina® and hosted by David A. Eichenbaum, MD, FASRS, partner and director of research at Retina Vitreous Associates of Florida in Tampa …
Notes de l’épisode
Eichenbaum Acorns is an editorially independent series powered by Modern Retina® and hosted by David A. Eichenbaum, MD, FASRS, partner and director of research at Retina Vitreous Associates of Florida in Tampa. This Q&A-style article and podcast series explore the overlooked corners of the retina specialist profession through candid conversations with thought leaders. Eichenbaum is the German translation for oak tree, and the aim of this series is to plant acorns of insight that grow into oaks of understanding.
In this installment, Eichenbaum chats with Jordan M. Graff, MD, FACS, of Barnet Dulaney Perkins Eye Center in Phoenix, Arizona, to discuss the realities of early adoption in retina care. Graff’s experience with the port delivery system (PDS) (Susvimo; Genentech), first as an investigator and later as one of the most active commercial utilizers in the US, provides insight into the opportunities and challenges of early adoption. He has navigated both the initial excitement of innovation and the realities of setbacks, including Genentech’s October 2022 voluntary recall following septum dislodgement issues. With the July 2024 reintroduction of a revised product, Graff offers a perspective on resuming adoption post-recall.Tsu Shan Chambers on "My Eyes" film: Bringing inherited eye disease to the screen
My Eyes, an Australian film created by actor, writer, and producer—and practicing optometrist—Tsu Shan Chambers, highlights the real-world challenges faced by families managing inherited eye disease and vision …
Notes de l’épisode
My Eyes, an Australian film created by actor, writer, and producer—and practicing optometrist—Tsu Shan Chambers, highlights the real-world challenges faced by families managing inherited eye disease and vision impairment. The Eye Care Network sat down with Chambers to discuss the film’s development and its role in raising awareness of eye health, particularly in relation to genetic conditions such as retinitis pigmentosa.
Note: The film initially premiered in markets including Australia and New Zealand and is now widely available on Amazon Prime Video. Updates on future screenings can be found by following FanForce.Beyond The Walls: The “how and why” behind what drives today’s ophthalmologists
In this inaugural episode of the Ophthalmology Times® “Beyond The Walls” podcast, host Deborah Ristvedt, DO, of Vance Thompson Vision, welcomes Marguerite B. McDonald, MD, FACS, a trailblazer in refractive …
Notes de l’épisode
In this inaugural episode of the Ophthalmology Times® “Beyond The Walls” podcast, host Deborah Ristvedt, DO, of Vance Thompson Vision, welcomes Marguerite B. McDonald, MD, FACS, a trailblazer in refractive surgery, dry eye research, and ophthalmic leadership.
The conversation traces McDonald’s journey from childhood experiences with severe myopia to her pioneering role in laser vision correction, as well as ongoing research and advice for the next generation of eye care professionals. McDonald is clinical professor of ophthalmology at NYU Langone Medical Center in New York and Tulane University Health Sciences Center in New Orleans, and in practice at OCLI Vision in Oceanside, NY.
Voici les 40 derniers épisodes sur 131. Les épisodes plus anciens se trouvent dans le flux du podcast.
Podcasts similaires
Plus de podcasts : Sciences
C’est votre podcast ?
Confirmez-le avec une entrée dans votre flux : vous recevez ici un code, vous l’ajoutez comme podcast:txt dans le canal de votre flux, et nous le vérifions. Votre podcast apparaît ensuite comme « vérifié » sur SoundNode.